EN
HI
Summary
As of 2 Nov, 2026, iSERA Lifesciences stock price is ₹143.9. During the trading session, the stock has moved between an intraday low of ₹143.90 and an intraday high of ₹143.90. Over the last 52 weeks, iSERA Lifesciences has traded between ₹8.14 and ₹151.05.
The stock has recorded a trading volume of 56 shares,. Its Average Traded Price (ATP) is ₹143.90, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 50 @ ₹143.90.
iSERA Lifesciences has an upper circuit limit of ₹143.90 and a lower circuit limit of ₹136.75. The total value traded stands at ₹8058.40, and the delivery percentage for the day is 100%.
The stock is currently traded with a market lot size of 1. iSERA Lifesciences also offers a dividend yield of 0%.
iSERA Lifesciences Share Price Chart
iSERA Lifesciences Share Key Metrics
Volume
56.00
Market Cap
353.88 CR
LTQ@LTP
50@143.90
ATP
143.9
Var Margin
100 %
Circuit Range
136.75-143.9
Delivery %
100 %
Value
8058.40
ASM/GSM
No
Market Lot
1
iSERA Lifesciences Resistance and Support
Pivot 143.9
Resistance
First Resistance
143.9
Second Resistance
143.9
Third Resistance
143.9
Support
First Support
143.9
Second Support
143.9
Third Support
143.9
iSERA Lifesciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Nov 02 2026 | 143.9 | 143.9 | 0.01% | 143.9 | 143.9 |
| Fri Oct 30 2026 | 143.89 | 143.89 | 0.00% | 143.89 | 143.89 |
| Wed Oct 28 2026 | 143.89 | 143.89 | 0.00% | 143.89 | 143.89 |
iSERA Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-07 | Quarterly Results |
| 2026-05-21 | Audited Results |
| 2026-04-20 | Preferential issue of shares |
| 2026-02-10 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-10-09 | Rights issue of Equity Shares |
| 2025-10-03 | Rights issue of Equity Shares |
| 2025-08-01 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-10 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-08-12 | Quarterly Results |
iSERA Lifesciences News
iSERA Lifesciences Ltd - 534920 - Board Meeting Intimation for To Consider, Approve And Take On Record The Un-Audited Financial Results Of The Company For The Quarter And Half Year Ended On September 30, 2026
iSERA Lifesciences board to meet on 4 November 2026 for financial results. The meeting will cover the quarter and half-year ended 30 September 2026.
Oct 31 2026 13:32:55
iSERA Lifesciences Ltd - 534920 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
iSERA Lifesciences promoters acquired a significant number of equity shares through a preferential allotment on a share swap basis on October 1, 2026. Key allottees include Shubhangi Garad (27,55,000 shares) and Sumeet Garad (11,92,000 shares).
Oct 08 2026 18:38:44
Read More
iSERA Lifesciences Management
| Name | Position |
|---|---|
| Jayshree Suresh | Managing Director |
| Jitendra Prabhakar Nene | Executive Director |
iSERA Lifesciences Similar Stocks
Dev Accelerator Ltd.
42.82
0.45 (1.06%)
Digispice Technologies Ltd.
16.32
0.18 (1.12%)
CyberTech Systems And Software Ltd.
121.70
-0.60 (0.49%)
Infinity Infoway Ltd.
680.00
4.00 (0.59%)
Ace Software Exports Ltd.
190.95
4.70 (2.52%)
XT Global Infotech Ltd.
26.94
1.54 (6.06%)
Sattrix Information Security Ltd.
304.00
13.00 (4.47%)
Tera Software Ltd.
242.00
-13.05 (5.12%)
iSERA Lifesciences FAQs
The Buying Price of iSERA Lifesciences share is 143.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy iSERA Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for iSERA Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of iSERA Lifesciences shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio iSERA Lifesciences shares is 0. Useful to assess the stock's value relative to its book value.
To assess iSERA Lifesciences’s valuation compare Sector P/E, P/B which are 33.3 & 2.89 with sector averages, along with growth rates and financial metrics.
The Market Cap of iSERA Lifesciences is 353.88 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of iSERA Lifesciences share price is 151.05 & 8.14. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
iSERA Lifesciences belongs to the Software and IT Services sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ISERA
